Low-dose mesenchymal stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility study.

Dan BatesDavid VivianJulien FreitagJames WickhamBruce MitchellPaul VerrillsKiran ShahRichard BoydDean FedermanAdele BarnardLera O'ConnorJacqui F Young

Published in: Future science OA (2022)

This study provides initial evidence of safety and efficacy of ADMSCs for discogenic LBP.

Keyphrases

low dose
mesenchymal stem cells
chronic pain
pain management
high dose
bone marrow
neuropathic pain
stem cells